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In the lung, Aspergillus fumigatus usually forms a dense colony of filaments embedded
in a polymeric extracellular matrix called biofilm (BF). This extracellular matrix embeds
and glues hyphae together and protects the fungus from an outside hostile environment.
This extracellular matrix is absent in fungal colonies grown under classical liquid shake
conditions (PL), which were historically used to understand A. fumigatus pathobiology.
Recent works have shown that the fungus in this aerial grown BF-like state exhibits
reduced susceptibility to antifungal drugs and undergoes major metabolic changes that are
thought to be associated to virulence. These differences in pathological and physiological
characteristics between BF and liquid shake conditions suggest that the PL condition is
a poor in vitro disease model. In the laboratory, A. fumigatus mycelium embedded by
the extracellular matrix can be produced in vitro in aerial condition using an agar-based
medium. To provide a global and accurate understanding of A. fumigatus in vitro BF
growth, we utilized microarray, RNA-sequencing, and proteomic analysis to compare the
global gene and protein expression profiles of A. fumigatus grown under BF and PL
conditions. In this review, we will present the different signatures obtained with these
three “omics” methods. We will discuss the advantages and limitations of each method
and their complementarity.
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INTRODUCTION
During lung infection, Aspergillus fumigatus hyphae are covered
by an extracellular matrix (Figures 1A,B) (Loussert et al., 2010).
In the case of aspergilloma, hyphae are embedded together in
this dense extracellular matrix whereas in invasive aspergillosis
hyphae are individually engulfed in the matrix (Figures 1A,B)
(Beauvais et al., 2007; Muller et al., 2011). This extracellular
matrix protects the fungus against host defense reactions as well
as antifungal drugs. The in vivo composition of the mycelial
extracellular matrix of A. fumigatus has been reported during
host infection (Loussert et al., 2010). The extracellular matrix is
composed of polysaccharides, pigment, and proteins. A. fumiga-
tus biofilm (BF) condition can be reproduced in vitro. Indeed,
the mycelium growing on porous plastic film deposited on the
surface of agar medium plate is able to form an extracellular
matrix with a composition closely similar to the in vivo with
tightly bound hyphae (Figure 1C) (Beauvais et al., 2007). In
contrast, this extracellular matrix is absent in mycelia grown
in shake cultures and hyphae are only loosely associated. These
differences in organizational and physiological characteristics
between the mycelium growing under “planktonic” or “biofilm”
condition are associated with specific transcriptional and trans-
lational signatures. As the development of the fungal BF in vivo
is more close to aerial colony grown on a solid substratum
in vitro, it is expected that an analysis of the colony physiology
may help to understand the in vivo growth of A. fumigatus in
patients.
High-throughput technologies enable quantitative monitoring
of the abundance of various biological molecules and allow quan-
tification of their variation between two different conditions on a
genomic scale. Omics approaches involve high-throughput tech-
nologies that enable the measurement of global changes in the
abundance of mRNA transcripts (transcriptomic), proteins (pro-
teomic), and other biomolecular components (metabolomic) in
complex biological systems as a result of chemical perturbation
or transition of developmental stages (Nie et al., 2007; Hawkins
et al., 2010; Ozsolak and Milos, 2011). Using “omics” methods
to compare the mycelium obtained in aerial condition vs. the
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FIGURE 1 | Transmission electron microscopy showing the
ultrastructure of A. fumigatus biofilm in vivo and in vitro.
(A) Invasive aspergillosis in human lung; (B) Aspergilloma in human
lung; and (C) 24 h static and aerial culture of A. fumigatus at 30◦C.
Note the presence of an extracellular material (ECM, arrow) at the
surface of the hyphae (H).
mycelium growing in submerged condition may allow us to
identify the biological process important during the BF growth.
In this review, we will present the different transcriptional
and translational signature obtained by using transcriptomic
(microarray and RNA-sequencing) and proteomic analyses of
BF grown mycelium in comparison to submerged mycelium. In
addition, since the application of omics technologies is quite at
its infancy in the A. fumigatus field, comparison of these three
“omics” methods makes it possible to highlight the advantages
and limitations or complementarity of these methods.
TRANSCRIPTOMIC ANALYSIS
A. fumigatus ATCC_46645 was the wild-type strain used in these
analyses. This genome is composed of 9.926 predicted genes orga-
nized in eight chromosomes for a total size of 29.4Mb (Niermann
et al., 2005). Total RNA of aerial colony or submerged mycelium
were obtained as described previously (Gibbons et al., 2012).
DATA OBTAINED WITH MICROARRAYS AND RNA-SEQUENCING
ANALYSIS
Four biological replicates of the microarray experiment were
performed, each time with a reciprocal labeling protocol (“dye-
swap”), which served both as a labeling control and techni-
cal replicate. The microarrays analysis was realized by using
the AF gene chip microarrays that cover about 9600 Open
Reading Frames from genome of strain ATCC_46645, sequenced
by J. Craig Venter Institute (JCVI), The Institute for Genomic
Research (TIGR). Scanning was performed with an Axon scanner
4000A and the resulting images were analyzed by using GenePix
Pro 6.01 software. The Bioplot software was used for statistical
analysis. Quantile normalization was applied to the whole data
set to account for variation between slides. Expression ratio cut-
off of 2.0 and 0.5 were applied to select differentially expressed
genes with a p-value <0.05 (Student’s t-test). 359 genes differen-
tially expressed in the BF condition as compared to submerged
condition were identified. Among them, 193 and 169 genes were
up or down regulated, respectively, under the BF growth condi-
tions. The differentially expressed genes were classified according
to the functional catalog FunCat. 66.84 and 59.17% of the up and
down regulated genes were functionally annotated, which led to
the identification of 6 functional categories significantly up regu-
lated and 14 functional categories down regulated in A. fumigatus
BF (p < 0.05 Fisher’s Exact Test) (Table 1). However, when we
considered the percentage of genes up or down regulated per cat-
egory, this percentage was too low to ascertain the global up or
down regulation of any of these functional categories.
The analysis of the transcriptional signature of the A. fumi-
gatus BF grown under the same conditions was already pub-
lished by Gibbons et al. (2012) by using RNA-sequencing. This
method identified 10-fold more genes differentially expressed in
the BF than microarrays. Among the 3729 differentially expressed
genes, 2564 genes were up regulated and 1164 genes were down
regulated in the BF. The functional categorization of the differ-
entially expressed genes showed a total of 31 up regulated and
31 down regulated functional categories under BF growth con-
ditions (Tables 2, 3). Among the different categories identified,
5 of the 6 up regulated categories and 9 of 14 down regulated
categories of the microarrays analysis are retrieved, respectively,
among up regulated and down regulated categories identified
by using RNA-sequencing (Tables 1, 2, 3). Among the most
highly enriched categories of the RNA-sequencing data, the cat-
egories linked to transport, detoxification, disease, virulence and
defense, and homeostasis were significantly up regulated whereas
the categories linked to carbohydrate metabolism such as glycol-
ysis/glucogenesis and tricarboxylic-acid cycle were significantly
down regulated.
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Table 1 | Functional categorization of the differentially expressed genes in the biofilm condition by using microarrays.
Number of hits Total of hits in % hits of the category Fisher’s exact
the category test p-value
CATEGORIES UP REGULATED IN BIOFILM BY USING MICROARRAYS
Translation 27 214 12.6 1.05E-13
Ribosome biogenesis 25 255 9.8 2.75E-10
Fungal/microorganismic cell type differentiation 21 485 4.3 0.0034
Lipid, fatty acid, and isoprenoid metabolism 8 746 1.1 0.0168
Protein binding 45 867 5.2 0.0337
RNA synthesis 11 1511 0.7 0.0341
CATEGORIES DOWN REGULATED IN BIOFILM BY USING MICROARRAYS
Disease, virulence, and defense 21 379 5.5 1.66E-06
Detoxification 20 407 4.9 1.89E-05
Respiration 11 155 7.1 7.34E-05
Fermentation 8 91 8.8 0.0002
DNA processing 1 578 0.2 0.0006
Protein binding 15 1511 1.0 0.0082
Nucleic acid binding 5 754 0.7 0.0108
Nucleotide/nucleoside/nucleobase metabolism 1 371 0.3 0.0213
Metabolism of vitamins, cofactors, and prosthetic groups 11 320 3.4 0.0265
Cell cycle 5 690 0.7 0.0287
Complex cofactor/cosubstrate/vitamine binding 14 441 3.2 0.0343
Stress response 18 635 2.8 0.0357
Secondary metabolism 16 551 2.9 0.0389
Lipid, fatty acid, and isoprenoid metabolism 20 746 2.7 0.0499
TRANSCRIPTOMIC SIGNATURE: MICROARRAY vs. RNA-SEQUENCING
ANALYSIS
Whereas the microarray analysis leads to the identification
of hundreds of differentially expressed genes, RNA-sequencing
allowed the identification of thousands of genes, which were dif-
ferentially expressed in the BF. For several categories more than
30% of hits constituting a specific FunCat category were differen-
tially expressed in the RNA-sequencing experiment. In constrast,
in microarray analyses no more than 12% of the hits belonging
to one category were differentially expressed (Tables 2, 3). Thus,
RNA-sequencing allows amore robust identification of functional
categories that represent the transcriptional signature of the BF
growth ofA. fumigatus (Tables 2, 3). Several reasons could explain
the difference between signatures obtained with these two meth-
ods and justify the current replacement of microarrays analysis by
RNA-sequencing data.
The development of microarrays enabled for the first time
the simultaneous analysis of the expression levels of thousands
of known or putative transcripts. However, microarrays provide
mRNA expression pattern data based on the high-throughput
and semi quantitative analysis of fluorescence signaling intensities
(Morozova et al., 2009). However, this technique has limita-
tions. As the technique relies on hybridization, it poses a range
of potential problems such as interfering background hybridiza-
tion levels, cross hybridization, difference in probe hybridization
properties, and dye binding variances. This technological bias
means that microarrays do not quantify easily and properly
the expression pattern of low abundant transcripts since low
intensity fluorescence signals are difficult to distinguish numer-
ically and statistically from the background noise (Roy et al.,
2011). Conversely, signal saturation can occur at high intensities
and limits the ability to compare transcripts that are expressed
at very high levels. In comparison, RNA-sequencing offers sev-
eral major advantages. Firstly, RNA-sequencing allows quantify-
ing gene expression levels precisely without any background by
sequencing each transcript independently (Wang et al., 2009).
Secondly, RNA-sequencing is very sensitive and can detect a
larger dynamic range of gene expression levels in comparison to
microarrays, without a lack of sensitivity for genes expressed at
very low or very high levels. Furthermore, RNA-sequencing has
showed a better reproducibility for both technical and biological
replicates. These methodological and technical variations inher-
ent to the methodologies themselves can explain the difference in
the number of differentially expressed genes obtained by applying
two methods to one experimental set-up.
In spite of these discrepancies, it was observed that among the
193 up regulated genes identified by microarrays, 119 were also
up regulated in the RNA-sequencing data (Figure 2A). Among
the 169 down regulated genes identified in the microarrays only
56 were shown to be down regulated in the RNA-sequencing
analysis (Figure 2B). Thus, ∼49% of the differentially expressed
genes identified with microarrays were also retrieved in the
RNA-sequencing data with a positive correlation of p = 0.82
(Pearson correlation) (Figure 2C). Some of the common differ-
entially expressed genes found in both transcriptomic methods
are discussed below (Table 4).
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Table 2 | Functional categorization of the up regulated biofilm genes obtained by using RNA-sequencing.
Categories up regulated in RNA-sequencing Number of hits Total of hits in % hits of the category Fisher’s exact
the category test p-value
Transport facilities 286 660 43.3 2.40E-19
Transported compounds (substrates) 476 1328 35.8 7.33E-13
Regulation of protein activity 83 499 16.6 7.99E-10
Cell cycle 128 690 18.6 1.52E-09
DNA processing 103 578 17.8 2.86E-09
Nucleus 43 304 14.1 5.55E-09
Nucleic acid binding 153 754 20.3 2.59E-07
Cellular signaling 89 485 18.4 3.50E-07
Ribosome biogenesis 108 255 42.4 4.73E-07
Homeostasis 118 286 41.3 6.88E-07
Protein binding 349 867 40.3 7.35E-07
RNA synthesis 184 1511 12.2 9.77E-07
Detoxification 154 407 37.8 7.32E-06
Regulation by 45 263 17.1 3.11E-05
Nucleotide/nucleoside/nucleobase binding 178 796 22.4 0.0001
Cytoskeleton/structural proteins 50 276 18.1 0.0001
Transport routes 352 1094 32.2 0.0006
Lipid, fatty acid, and isoprenoid metabolism 247 746 33.1 0.0010
Aminoacyl-tRNA-synthetases 3 44 6.8 0.0010
Mitochondrion 25 151 16.6 0.0012
Bud/growth tip 1 29 3.4 0.0014
Translation 81 214 37.9 0.0014
Stress response 145 635 22.8 0.0023
Cell growth/morphogenesis 74 348 21.3 0.0037
Transmembrane signal transduction 34 171 19.9 0.0155
RNA processing 98 425 23.1 0.0184
Glycolysis and gluconeogenesis 21 115 18.3 0.0205
Disease, virulence, and defense 126 379 33.2 0.0208
Phosphate metabolism 139 575 24.2 0.0350
Structural protein binding 9 58 15.5 0.0385
Metabolism of vitamins, cofactors, and prosthetic groups 74 320 23.1 0.0470
A large proportion of common genes up regulated in the
BF are involved in the transcriptional and translational regula-
tion reflecting the establishment of different transcriptional and
translational programs between these two growth conditions.
Genes coding for antigenic and allergenic proteins are dif-
ferentially expressed in the BF. Two of the major allergens of
A. fumigatus, the ribotoxin Asp F1 and the allergen Asp F7-like
(extracellular cellulase CelA) are up regulated in the A. fumigatus
BF (Madan et al., 1997a,b; Alvarez-Garcia et al., 2010). Among
the 81 allergens identified in A. fumigatus, 39 genes were shown
to be up regulated under BF conditions by using RNA-sequencing
(Mari and Scala, 2006). Noteworthy, the secreted galactomanno-
protein Afmp1p and the mannoprotein Afmp2p are up regulated
in the BF (Woo et al., 2002; Chong et al., 2004). Afmp1p and
Afmp2p are specific to A. fumigatus and are not found in other
Aspergillus species. A clinical evaluation of sera from invasive
aspergillosis patients has revealed that they contained circulat-
ing Afmp1p proteins as well as antibodies directed against both
Afmp1p and Afmp2p proteins. A dual detection system was
suggested for the diagnosis of aspergillosis based on the presence
of circulating Afmp1 antigen and antibodies against Afmp2p. An
overexpression of antigenic molecule does not occur in all cases,
e.g., the allergen thioredoxin peroxidase AspF3 is down regulated
in the BF (Kniemeyer et al., 2009). The occurrence of a higher
production of allergens/antigens in the BF condition is in agree-
ment with the initial observations that growth of the fungus in an
infected lung is similar to the in vitro BF growth.
The rodB gene belonging to the hydrophobins family is also
highly up regulated in the BF. A. fumigatus has at least six
genes that code for hydrophobins, but only rodA and rodB have
been studied for virulence implications (Paris et al., 2003). The
rodA gene encodes a small hydrophobic cysteine-rich polypep-
tide present on the surface of the conidia and the deletion mutant
displays a conidial cell wall without rodlet layer allowing a better
recognition to alveolar macrophages. The rodA mutant produced
smaller lung lesions and weaker inflammatory response than
the reference wild-type strain in a murine model of invasive
aspergillosis. However, although the rodB gene is highly expressed
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Table 3 | Functional categorization of the down regulated biofilm genes obtained by RNA-sequencing.
Categories down regulated in RNA-sequencing Number of hits Total of hits in % hits of the category Fisher’s exact
the category test p-value
Transport facilities 32 660 4.8 6.81E-12
Ribosome biogenesis 6 255 2.4 8.17E-09
Glycolysis and gluconeogenesis 37 115 32.2 1.58E-08
Transported compounds (substrates) 116 1328 8.7 2.35E-06
Nucleus 62 304 20.4 4.84E-05
Stress response 111 635 17.5 7.11E-05
RNA synthesis 140 1511 9.3 0.0004
Regulation of protein activity 87 499 17.4 0.0006
Disease, virulence, and defense 28 379 7.4 0.0016
Bud/growth tip 10 29 34.5 0.0018
Fermentation 22 91 24.2 0.0018
Complex cofactor/cosubstrate/vitamine binding 76 441 17.2 0.0020
C-compound and carbohydrate metabolism 200 1346 14.9 0.0021
Tricarboxylic-acid pathway (citrate cycle, Krebs cycle, and TCA cycle) 15 53 28.3 0.0023
Translation 13 214 6.1 0.0029
Transport routes 107 1094 9.8 0.0036
Protein folding and stabilization 28 132 21.2 0.0045
Nucleic acid binding 116 754 15.4 0.0090
Transmembrane signal transduction 33 171 19.3 0.0090
DNA processing 92 578 15.9 0.0092
Fungal/microorganismic cell type differentiation 79 485 16.3 0.0093
Cell growth/morphogenesis 59 348 17.0 0.0115
Extracellular metabolism 1 56 1.8 0.0122
Nitrogen, sulfur and selenium metabolism 47 275 17.1 0.0188
Homeostasis 23 286 8.0 0.0210
Nucleotide/nucleoside/nucleobase metabolism 32 371 8.6 0.0223
Respiration 28 155 18.1 0.0352
Cell cycle 103 690 14.9 0.0359
Metabolism of energy reserves (e.g., glycogen and trehalose) 14 66 21.2 0.0373
Anaplerotic reactions 2 3 66.7 0.0422
Nucleotide/nucleoside/nucleobase binding 116 796 14.6 0.0485
in the BF, the rodB deletion mutant did not show any obvi-
ous morphological phenotypes. The role of this hydrophobin in
mycelial growth remains obscure.
The gene coding for the putative O-methyltransferase CalO6
is one of the most up regulated gene in the BF found in both
analyses. This gene belongs to a secondary metabolism superclus-
ter responsible for the biosynthesis of fumitremorgin, pseurotin
A, and an unknown secondary metabolite (Khaldi et al., 2010).
Among this supercluster composed of 44 genes, 3 genes were
found to be up regulated in the microarray data set in com-
parison to 32 up regulated genes identified by RNA-sequencing.
Fumitremorgin was shown to be an inhibitor of chemotherapy-
resistant breast cancer cells and conferred sensitivity to anticancer
drugs (Grundmann et al., 2008). In spite of these interesting bio-
logical characteristics, the potential role of fumitremorgins in
Aspergillus pathogenesis has not been elucidated yet. The role
of the pseurotin A toxin in the pathogenesis of A. fumigatus
is also poorly understood (Ishikawa et al., 2009; Vodisch et al.,
2011). The pseurotin A toxin was shown to be produced under
hypoxic conditions and showed a slight cytotoxicity against lung
fibroblasts and the capacity to inhibit IgE production (Ishikawa
et al., 2009). Most of the studies on Aspergillus fumigatus myco-
toxins dealt with gliotoxin. The corresponding gene cluster of
gliotoxin is up regulated in the BF (Bruns et al., 2010; Speth
et al., 2011; Scharf et al., 2012). Even though their role in fungal
pathogenicity was suggested by these studies, their role dur-
ing infection has not been experimentally assessed using pure
substance.
RNA-sequencing as compared to microarrays provides clear
evidence that entire pathways are differentially expressed. For
example, the glycolysis pathway responsible for the conversion
of glucose to pyruvate was shown to be down regulated in
the A. fumigatus BF in both transcriptomic methods. Whereas
microarrays allowed the identification of only 5 down regu-
lated genes of the glycolysis, the RNA-sequencing highlighted 17
down regulated genes out of 28 genes constituting the glycolysis
pathway (Figure 3). Genes encoding enzymes of the tricarboxylic-
acid cycle are also differentially expressed as revealed by both
transcriptomic methods. Genes encoding enzymes responsible of
the conversion of citrate to succinyl-CoA, the oxidative branch
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FIGURE 2 | Identification of the differentially expressed genes common
to both transcriptomic methods. (A) Comparison of the up regulated
genes obtained with microarray and RNA-sequencing analysis in the biofilm.
(B) Comparison of the down regulated genes obtained with microarray and
RNA-sequencing analysis in the biofilm. (C) Comparison of the fold change
obtained with microarray and RNA-sequencing analysis.
of the TCA cycle, were shown to be down regulated in RNA-
sequencing whereas enzymes participating in the conversion of
succinyl-CoA to oxaloacetate were shown to be up regulated. In
line with this, the isocitrate lyase, which is involved in the con-
version of isocitrate to glyoxylate and succinate was shown to
be up regulated in both analyses. These results reflect that the
fungus may not acquire energy by fermentation but by metabo-
lizing acetyl-CoA using the glyoxylate cycle under BF conditions.
NADH formed by this cycle can enter then in the respiratory
chain pathway. Genes belonging to the mitochondrial complexes
II, III, and V, controlling oxidative phosphorylation, were shown
to be up regulated in the BF in the RNA-sequencing analysis. In
Candida albicans, levels of isocitrate lyase and malate synthase are
greatly increased upon contact with its human host and interest-
ingly, isocitrate lyase has been shown to be key virulence factor
(Lorenz and Fink, 2001). In contrast, isocitrate lyase of A. fumi-
gatus is not essential for the development of invasive aspergillosis
in a murine model (Schobel et al., 2007).
One hundred and forty transporter genes were up regulated
in the BF based on RNA-sequencing analysis. In comparison,
microarrays revealed only the up regulation of only 5 MFS and
3 ABC transporters. The Mdr4 transporter was shown to be
up regulated in an in vivo BF mouse model during voricona-
zole treatment (Langfelder et al., 2002; Nascimento et al., 2003;
Rajendran et al., 2011). The ABC transporters Mdr1, Mdr2, and
Mdr4 which are overexpressed in itraconazole-resistant mutants
induced in vitro are also up regulated in our BF condition in
the RNA-sequencing analysis (Nascimento et al., 2003). Thus, the
up regulation of these efflux pumps in A. fumigatus could lead
to azole resistance in BF grown A. fumigatus cultures. A recent
study showed that the A. fumigatus BF sensitivity to voriconazole
was increased in presence of an efflux pump inhibitor reflecting
the importance of the transport activity in the BF to counteract
the action of inhibitors in association with the 14-α-demethylase
Cyp51A (Rajendran et al., 2011).
PROTEOMICS ANALYSIS
Large-scale analysis of the proteome is also important for a better
understanding of the cellular, metabolic, and regulatory networks
in the cell. Proteomic analysis offers the advantage to visualize the
final product of the gene transcription. This methodology has still
a bias against low-abundance and membrane proteins. However,
targeted proteomic approaches based on LC-MS/MS techniques,
such as selected reaction monitoring (SRM), have the potenial
to detect proteins with low copy numbers (Picotti et al., 2009).
In A. fumigatus, around 650 proteins have so far been identi-
fied by 2D-gel electrophoresis for a genome that has ∼10,000
genes (Teutschbein et al., 2010). The proteomic analysis of the
BF condition after 16 h growth as compared to submerged con-
dition was performed as described by Bruns et al. (2010), with
Frontiers in Microbiology | Fungi and Their Interactions February 2013 | Volume 4 | Article 13 | 6
Muszkieta et al. “Omics” and biofilm of Aspergillus fumigatus
Table 4 | List of differentially expressed genes common to both transcriptomic methods used.
Accession number Gene function Microarray ratios Log2 fold change of RNA-seq ratio Log2 fold change
of intensities ratio intensities of counts of counts
AFUA_8G00200 CalO6, putative 12.39 3.63 9885.95 13.27
AFUA_1G17250 Conidial hydrophobin RodB 16.54 4.05 4118.35 12.01
AFUA_6G11850 Hypothetical protein 8.61 3.11 3408.58 11.73
AFUA_7G06620 Related to L-fucose permease,
putative
2.41 1.27 243.13 7.93
AFUA_4G03240 Cell wall galactomannoprotein Mp1 5.6 2.49 238.51 7.90
AFUA_8G00900 Cell surface antigen spherulin 4,
putative
7.31 2.87 212.52 7.73
AFUA_5G08800 Hypothetical protein 8.32 3.06 155.28 7.28
AFUA_3G01500 Hypothetical protein 4.89 2.29 117.44 6.88
AFUA_5G13250 DUF614 domain protein 9.8 3.29 98.50 6.62
AFUA_1G14560 Alpha-mannosidase 3.99 2.00 84.72 6.40
AFUA_1G00990 Short chain dehydrogenase/
reductase family protein
4.02 2.01 79.69 6.32
AFUA_4G13050 Hypothetical protein 3.07 1.62 77.73 6.28
AFUA_4G01350 Hypothetical protein 3.97 1.99 73.93 6.21
AFUA_1G10390 ABC multidrug transporter, putative 2.06 1.04 64.23 6.01
AFUA_4G03330 DUF590 domain protein, putative 3.83 1.94 47.61 5.57
AFUA_1G03350 Alpha-1,3-glucanase, putative 3.73 1.90 44.20 5.47
AFUA_7G00420 Hypothetical protein 2.79 1.48 41.86 5.39
AFUA_4G07810 L-serine dehydratase, putative 4.67 2.22 38.63 5.27
AFUA_4G08370 Conserved hypothetical protein 3.68 1.88 37.09 5.21
AFUA_5G02330 Major allergen Asp F1 36.71 5.20 34.45 5.11
AFUA_6G02220 MFS toxin efflux pump, putative 3.64 1.86 33.48 5.07
AFUA_8G00410 Methionine aminopeptidase, type II,
putative
3.02 1.59 32.34 5.02
AFUA_6G14340 Related to berberine bridge enzyme
[imported]
8.28 3.05 31.45 4.98
AFUA_1G12560 Endo-1,4-beta-glucanase, putative 9.66 3.27 31.32 4.97
AFUA_1G14800 Hypothetical protein 2.62 1.39 30.98 4.95
AFUA_2G15200 Conserved hypothetical protein 3.04 1.60 30.59 4.94
AFUA_4G08380 Hypothetical protein 8.98 3.17 27.58 4.79
AFUA_2G15290 DUF636 domain protein 18.7 4.22 27.06 4.76
AFUA_2G09030 Secreted dipeptidyl peptidase 5.67 2.50 27.02 4.76
AFUA_3G03670 ABC multidrug transporter, putative 4.38 2.13 26.18 4.71
AFUA_5G13950 Conserved hypothetical protein 2.72 1.44 25.98 4.70
AFUA_1G02290 Conserved hypothetical protein 5.28 2.40 25.11 4.65
AFUA_1G06350 Virulence related protein (Cap20),
putative
3.35 1.74 25.04 4.65
AFUA_1G14430 Chitin binding protein, putative 9.66 3.27 24.90 4.64
AFUA_4G09400 Aspartic-type endopeptidase (AP3),
putative
3 1.58 23.10 4.53
AFUA_2G00500 Conserved hypothetical protein 3.54 1.82 19.95 4.32
AFUA_3G03650 Acetyltransferase, GNAT family,
putative
7.88 2.98 19.03 4.25
AFUA_3G08610 DUF124 domain protein 4.91 2.30 17.08 4.09
AFUA_6G13830 Oxidoreductase, short chain
dehydrogenase/reductase family
2.89 1.53 16.14 4.01
AFUA_1G00930 Hypothetical protein 2.95 1.56 15.40 3.94
(Continued)
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Table 4 | Continued
Accession number Gene function Microarray ratios Log2 fold change of RNA-seq ratio Log2 fold change
of intensities ratio intensities of counts of counts
AFUA_4G09390 Conserved hypothetical protein 3.38 1.76 15.15 3.92
AFUA_3G03640 Siderochrome-iron transporter
(MirB), putative
5.17 2.37 13.62 3.77
AFUA_6G12170 FKBP-type peptidyl-prolyl isomerase,
putative
3.61 1.85 11.97 3.58
AFUA_7G00250 Tubulin beta-2 subunit 5.13 2.36 11.46 3.52
AFUA_3G02010 Cytochrome P450 monooxygenase,
putative
2.57 1.36 11.46 3.52
AFUA_8G06490 Conserved hypothetical protein 3.3 1.72 11.15 3.48
AFUA_5G03780 L-PSP endoribonuclease family
protein
3.96 1.99 10.34 3.37
AFUA_2G13500 Hypothetical protein 3.05 1.61 9.47 3.24
AFUA_1G01160 Salivary apyrase, putative 3.22 1.69 9.15 3.19
AFUA_2G16060 Conserved hypothetical protein 2.43 1.28 8.56 3.10
AFUA_2G04080 GPR/FUN34 family protein 5.72 2.52 7.70 2.94
AFUA_7G06540 Low-specificity L-threonine aldolase,
putative
3.15 1.66 7.19 2.85
AFUA_4G09220 Hypothetical protein 2.72 1.44 6.85 2.78
AFUA_8G02060 Glycan biosynthesis protein (PiGL),
putative
2.11 1.08 6.47 2.69
AFUA_3G00340 Glycosyl hydrolase, putative 2.86 1.52 6.11 2.61
AFUA_3G12300 Ribosomal L22e protein family 2.82 1.50 5.60 2.49
AFUA_4G00200 F-box domain protein 2.91 1.54 5.45 2.45
AFUA_2G16070 Urease accessory protein UreD 4.84 2.28 5.34 2.42
AFUA_5G06320 Membrane biogenesis protein
(Yop1), putative
2.1 1.07 5.30 2.41
AFUA_2G15130 ABC multidrug transporter, putative 6.9 2.79 5.03 2.33
AFUA_1G03110 Ribosomal protein L29 2.1 1.07 4.98 2.31
AFUA_5G14930 Conserved hypothetical protein 3.74 1.90 4.87 2.29
AFUA_6G12660 40s ribosomal protein 3.09 1.63 4.74 2.24
AFUA_8G00960 Cytochrome P450, putative 4.29 2.10 4.43 2.15
AFUA_1G15020 40s ribosomal protein S5 2.88 1.53 4.13 2.05
AFUA_5G03490 Nucleoside diphosphate kinase 2.17 1.12 4.12 2.04
AFUA_2G06150 Disulfide isomerase, putative 2.34 1.23 3.90 1.96
AFUA_5G00230 Hypothetical protein 4.09 2.03 3.84 1.94
AFUA_6G07290 Endosomal cargo receptor (Erv14),
putative
2.63 1.40 3.73 1.90
AFUA_1G16690 MFS transporter, putative 2.06 1.04 3.73 1.90
AFUA_3G06710 Ubiquitin thiolesterase (OtuB1),
putative
2.28 1.19 3.61 1.85
AFUA_3G11260 Ubiquitin (UbiC), putative 2.12 1.08 3.57 1.83
AFUA_3G07890 Endo alpha-1,4
polygalactosaminidase, putative
3.47 1.79 3.54 1.82
AFUA_6G04780 Vacuolar protein sorting 55
superfamily
2.43 1.28 3.46 1.79
AFUA_5G11850 Mitochondrial carrier protein (Pet8),
putative
2.12 1.08 3.39 1.76
AFUA_5G05450 Ribosomal protein S3Ae cytosolic 2.28 1.19 3.29 1.72
AFUA_6G00680 Hypothetical protein 4.11 2.04 3.26 1.71
(Continued)
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Table 4 | Continued
Accession number Gene function Microarray ratios Log2 fold change of RNA-seq ratio Log2 fold change
of intensities ratio intensities of counts of counts
AFUA_5G02780 Nicotinamide nucleotide
transhydrogenase
2.61 1.38 3.24 1.70
AFUA_1G04040 Ubiquitin (UbiA), putative 2.89 1.53 3.23 1.69
AFUA_1G16030 Conserved hypothetical protein 2.61 1.38 3.22 1.69
AFUA_6G13250 Ribosomal protein L31e 2.16 1.11 3.19 1.68
AFUA_2G05150 Putative cell wall
galactomannoprotein Mp2/allergen
F17-like
7.91 2.98 3.14 1.65
AFUA_3G13320 40s ribosomal protein S0, putative 2.6 1.38 3.13 1.64
AFUA_6G03830 Ribosomal protein L14 3.04 1.60 3.09 1.63
AFUA_1G10380 Nonribosomal peptide synthase
(NRPS)
3.63 1.86 3.09 1.63
AFUA_1G04660 Ribosomal L15 2.08 1.06 3.06 1.61
AFUA_4G01290 Endo-chitosanase, pseudogene 15.82 3.98 3.01 1.59
AFUA_3G10730 Ribosomal protein S7e 2.16 1.11 3.00 1.59
AFUA_5G09400 Carbonyl reductase, putative 3.64 1.86 3.00 1.59
AFUA_4G04070 Conserved hypothetical protein 2.06 1.04 2.96 1.57
AFUA_2G14490 Endoglucanase, putative 32.7 5.03 2.90 1.54
AFUA_4G13080 Monosaccharide transporter 3.91 1.97 2.88 1.53
AFUA_3G05600 Ribosomal protein L27a 2.14 1.10 2.88 1.53
AFUA_7G01590 Cystathionine gamma-synthase 2.11 1.08 2.81 1.49
AFUA_7G05300 Hypothetical protein 3.1 1.63 2.78 1.47
AFUA_1G09510 GPI anchored protein, putative 3.55 1.83 2.76 1.46
AFUA_4G00800 MFS monosaccharide transporter,
putative
7.39 2.89 2.73 1.45
AFUA_5G08030 Cellulase CelA, putative 2.23 1.16 2.69 1.43
AFUA_7G04290 Amino acid permease (Gap1),
putative
3.43 1.78 2.68 1.42
AFUA_5G03010 Conserved hypothetical protein 6.64 2.73 2.66 1.41
AFUA_1G11670 Small nuclear ribonucleoprotein
(LSM8)
2.21 1.14 2.53 1.34
AFUA_4G03760 Glycine dehydrogenase 2.79 1.48 2.51 1.33
AFUA_1G11130 60s ribosomal protein yl16a 2.37 1.24 2.48 1.31
AFUA_1G09530 Conserved hypothetical protein 2.24 1.16 2.48 1.31
AFUA_3G06640 40s ribosomal protein s27 type 2.32 1.21 2.47 1.31
AFUA_7G05290 Cytosolic small ribosomal subunit
S15, putative
2.31 1.21 2.43 1.28
AFUA_4G07300 Hypothetical protein 4.85 2.28 2.42 1.27
AFUA_2G02150 Ribosomal protein S10 2.32 1.21 2.40 1.27
AFUA_1G12350 Extracellular fruiting body protein,
putative
8.63 3.11 2.39 1.26
AFUA_3G06840 Cytosolic small ribosomal subunit
S4, putative
2.41 1.27 2.30 1.20
AFUA_2G02990 MYB DNA-binding domain protein 2.43 1.28 2.27 1.18
AFUA_5G02950 Conserved hypothetical protein 2.7 1.43 2.24 1.16
AFUA_7G08240 Hypothetical protein 2.03 1.02 2.17 1.12
AFUA_1G08880 Heavy metal ion transporter,
putative
2.35 1.23 2.10 1.07
AFUA_6G12820 MAP kinase (FUS3/KSS1), putative 3.84 1.94 2.06 1.04
(Continued)
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Table 4 | Continued
Accession number Gene function Microarray ratios Log2 fold change of RNA-seq ratio Log2 fold change
of intensities ratio intensities of counts of counts
AFUA_7G02570 Heterokaryon incompatibility protein
(Het-C)
3.96 1.99 2.05 1.04
AFUA_1G06770 Ribosomal protein S26e 2.98 1.58 2.03 1.02
AFUA_6G06500 Actin-related protein 2/3 complex
subunit 1A
2.13 1.09 2.02 1.02
AFUA_5G09750 Nucleoside transporter, putative 2.94 1.56 2.01 1.01
AFUA_1G09690 tRNA liGase 0.37 −1.43 0.49 −1.03
AFUA_7G04010 Conserved hypothetical protein 0.44 −1.18 0.49 −1.03
AFUA_5G01030 Glyceraldehyde 3-phosphate
dehydrogenase
0.03 −5.06 0.49 −1.04
AFUA_2G09510 Hypothetical protein 0.17 −2.56 0.48 −1.05
AFUA_4G11560 Vacuolar protein sorting-associated
protein vps13
0.45 −1.15 0.48 −1.05
AFUA_2G11460 C6 finger domain protein, putative 0.32 −1.64 0.46 −1.12
AFUA_6G02280 Allergen Asp F3 0.32 −1.64 0.45 −1.16
AFUA_2G15430 L-xylulose reductase 0.13 −2.94 0.44 −1.19
AFUA_1G01600 Deoxyribodipyrimidine photolyase 0.2 −2.32 0.42 −1.25
AFUA_7G01800 AT DNA binding protein, putative 0.27 −1.89 0.41 −1.28
AFUA_3G00370 D-fructose 6-phosphate
phosphoketolase
0.08 −3.64 0.40 −1.32
AFUA_3G03400 Siderophore biosynthesis protein,
putative
0.46 −1.12 0.39 −1.35
AFUA_2G04190 Hypothetical protein 0.28 −1.84 0.37 −1.44
AFUA_2G06270 Hypothetical protein 0.38 −1.40 0.35 −1.53
AFUA_2G13030 Phenylalanyl-tRNA synthetase alpha
subunit (PodG)
0.36 −1.47 0.32 −1.63
AFUA_5G11190 Hypothetical protein 0.14 −2.84 0.32 −1.64
AFUA_5G10660 Pentatricopeptide repeat protein 0.34 −1.56 0.32 −1.66
AFUA_5G08200 Hypothetical protein 0.25 −2.00 0.31 −1.70
AFUA_2G11840 Transcriptional corepressor (Cyc8),
putative
0.42 −1.25 0.30 −1.75
AFUA_3G14590 Copper amine oxidase 0.28 −1.84 0.28 −1.85
AFUA_2G09350 Endo-beta-1,6-glucanase, putative 0.37 −1.43 0.27 −1.88
AFUA_2G05450 64kDa mitochondrial NADH
dehydrogenase
0.41 −1.29 0.27 −1.92
AFUA_4G08170 Succinate-semialdehyde
dehydrogenase
0.43 −1.22 0.25 −1.98
AFUA_5G14680 Hypothetical protein 0.18 −2.47 0.25 −2.02
AFUA_8G05380 Hypothetical protein 0.48 −1.06 0.22 −2.21
AFUA_2G01140 GPI anchored protein, putative 0.31 −1.69 0.21 −2.23
AFUA_2G07680 L-ornithine N5-oxygenase 0.46 −1.12 0.21 −2.25
AFUA_3G05780 GATA transcription factor (LreA),
putative
0.13 −2.94 0.20 −2.29
AFUA_2G16520 Phospholipase D (PLD), putative 0.42 −1.25 0.20 −2.30
AFUA_6G04920 NAD-dependent formate
dehydrogenase
0.27 −1.89 0.17 −2.57
AFUA_8G05600 Hypothetical protein 0.07 −3.84 0.16 −2.64
AFUA_1G13800 mfs-multidrug-resistance
transporter
0.28 −1.84 0.16 −2.65
(Continued)
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Table 4 | Continued
Accession number Gene function Microarray ratios Log2 fold change of RNA-seq ratio Log2 fold change
of intensities ratio intensities of counts of counts
AFUA_5G06240 Alcohol dehydrogenase. putative 0.09 −3.47 0.15 −2.72
AFUA_8G05580 Coenzyme A transferase PsecoA 0.19 −2.40 0.15 −2.76
AFUA_4G08960 GPI anchored protein, putative 0.19 −2.40 0.14 −2.86
AFUA_2G13830 Conserved hypothetical protein 0.41 −1.29 0.13 −2.95
AFUA_5G07590 Hypothetical protein 0.32 −1.64 0.13 −2.96
AFUA_7G08280 Hypothetical protein 0.35 −1.51 0.12 −3.02
AFUA_2G09220 Hypothetical protein 0.31 −1.69 0.12 −3.04
AFUA_1G03610 Hypothetical protein 0.11 −3.18 0.12 −3.05
AFUA_1G12250 Mitochondrial hypoxia responsive
protein
0.16 −2.64 0.12 −3.07
AFUA_1G10610 Hypothetical protein 0.27 −1.89 0.11 −3.16
AFUA_6G13380 Hypothetical protein 0.4 −1.32 0.11 −3.24
AFUA_3G05760 C6 transcription factor (Fcr1),
putative
0.09 −3.47 0.10 −3.34
AFUA_4G11720 Phosphatidyl synthase 0.12 −3.06 0.10 −3.39
AFUA_1G12840 Nitrite reductase 0.2 −2.32 0.09 −3.49
AFUA_5G12530 Conserved hypothetical protein 0.42 −1.25 0.08 −3.68
AFUA_4G03460 HLH DNA binding domain protein,
putative
0.13 −2.94 0.08 −3.72
AFUA_3G11070 Pyruvate decarboxylase PdcA,
putative
0.1 −3.32 0.07 −3.80
AFUA_3G10750 Acetate kinase, putative 0.34 −1.56 0.06 −4.04
AFUA_4G03410 Flavohemoprotein 0.07 −3.84 0.05 −4.32
AFUA_1G12830 Nitrate reductase NiaD 0.14 −2.84 0.05 −4.40
AFUA_1G15270 ATP-dependent Clp protease,
putative
0.17 −2.56 0.02 −5.44
AFUA_3G14540 30 kDa heat shock protein 0.23 −2.12 0.02 −5.44
AFUA_2G05060 Alternative oxidase 0.03 −5.06 0.02 −5.86
AFUA_5G02700 Multidrug resistant protein 0.07 −3.84 0.01 −6.09
slight modifications. 2D-gel images were analyzed by using Delta
2D 4.3 (Decodon, Germany). Analysis of the 2-D gel patterns
obtained revealed that 43 spots showed significant changes in
abundance between the BF and planktonic cultures (Figure 4).
Among them, 25 different proteins were identified by MALDI-
TOF/TOF-analyses (Table 5). Three proteins were up and 22 were
down regulated under BF conditions.
PROTEOMIC vs. RNA-SEQ DATA
The comparison of the transcriptomic and proteomic data has
revealed that 16 genes corresponding to differentially regulated
proteins were retrieved in the RNA-sequencing data vs. only 5
genes for microarrays. Only 8 of the 22 down regulated proteins
and corresponding mRNAwere found to be down regulated (cut-
off<0.5) with a correlation of p = 0.43 (Pearson correlation) and
one protein and its correspondingmRNAwas up regulated. These
results stressed the difficulties in correlating transcriptome and
proteome data. Several reasons may explain the low number of
differentially expressed proteins and the low degree of correla-
tion between transcriptomic and proteomic analyses (Nie et al.,
2007; Sukardi et al., 2010). For technical reasons, the current two-
dimensional gel-based analyses focus mainly on the cytoplasmic
subset of the cell proteome due to the impossibility to date to
extract most membrane or hydrophobic proteins. Proteins are
then separated according to their isoelectric point and molecular
mass. So proteins with an extreme isoelectric point or molecu-
lar mass are not amenable to 2D-gel electrophoresis. A sufficient
amount of protein present in one spot is also crucial for the
unambiguous identification of the protein by MALDI-TOF/TOF-
analyses. Conversely, RNA-sequencing allows the identification
of thousand mRNAs differentially regulated between two condi-
tions. However, the transcript levels detected in mRNA profiling
do not reflect all the regulatory processes in the cell, such as
post-transcriptional-processes occurring before translation, the
half-lives of mRNAs and proteins and the post-translational reg-
ulation on the protein level as the quality control of proteins
and the degradation in the proteasome. Conversely to RNA-
sequencing, the proteomic analysis highlights fewer regulated
proteins but assured their real up regulation or down regula-
tion in the cell. Thus, even if a limited number of proteins were
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FIGURE 3 | Differential expression of genes involved in glycolysis pathway and TCA cycle during biofilm growth.
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FIGURE 4 | 2D electrophoretic separation of protein extracts of A.
fumigatus grown under submerged (PL) and biofilm (BF) culture
conditions. In total, 43 different protein spots of A. fumigatus changed
significantly their abundance within 16 h of growth (protein spots are labeled
with spot numbers as indicated in Table 5). A. fumigatus proteins were
labeled with the CyDye DIGE Fluor minimal dye labeling kit. Subsequently,
proteins were separated by 2D gel electrophoresis using immobilized pH
gradient strips with a pH range of 3–11 NL in the first dimension. For the
separation of proteins in the second dimension, SDS-polyacrylamide
gradients gels (11–16%) were used. Differentially regulated proteins were
identified by MALDI-TOF/TOF analysis. A three color overlaid gel image is
shown. Samples were labeled as follows: ATCC 46645-planctonic culture
control sample (Cy3), ATCC 46645-biofilm culture sample (Cy5), and internal
standard (Cy2).
identified by proteomic analysis, some of them could confirm the
up regulation of pathways or genes in the BF at the protein level.
Among the proteins identified, proteins involved in the
translational regulation and post-translational modifications are
found. The data were in agreement with the transcriptomic data
and shows that the transcriptional and translational processes
involved in the two growth conditions were different.
Similarly, the pyruvate kinase was down regulated whereas the
acetyl-CoA synthetase FacA and the malate dehydrogenase were
up regulated in the BF. These results confirmed the down regula-
tion of the glycolysis pathway and the up regulation of final steps
of the TCA at the protein level.
The Asp-hemolysin protein was down regulated in the BF.
Asp-hemolysin was reported to be released into the culture super-
natant by A. fumigatus during growth in presence of elastin,
collagen, and keratin, where it is supposed to exhibit a hemolytic
activity (Wartenberg et al., 2011). However, the characteriza-
tion of the deletion strain asp-HS did not revealed significant
hemolytic and cytotoxic activity and the impact on pathogenic-
ity and the biological role of the Asp-HS protein is still poorly
understood.
All proteome data (gel images, spot information) were
imported into our in-house data ware-house Omnifung http://
www.omnifung.hki-jena.de and are publicly accessible.
CONCLUSIONS
In recent years, many high-throughput technologies have been
developed to decipher various aspects of cellular processes,
including the transcriptome, epigenome, proteome, metabolome,
or interactome. The capacity to perform “omics” analyses
at several different levels, such as transcriptomic, proteomic,
or metabolomics, and their comparison and integration of
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Table 5 | List of differentially expressed proteins obtained by using proteomic analysis.
Accession number Spot numbera Putative function Proteomic ratio of biofilm/ RNA-seq ratio of biofilm/
planctonic conditionsb planctonic conditionsc
1 AFUA_1G05340 38 40s ribosomal protein S19 0.43 4.21
2 AFUA_1G07480 15 Coproporphyrinogen III oxidase 0.39
3 AFUA_1G12890 20 Probable 60s ribosomal protein l5 0.40
22 0.40
4 AFUA_1G14120 11 Nuclear segregation protein (Bfr1) 0.47
5 AFUA_1G16840 32 TCTP family protein 0.43 2.96
6 AFUA_2G04060 15 NADH:flavin Oxidoreductase/NADH
oxidase family protein
0.39 0.14
7 AFUA_2G07420 6 Actin-bundling protein Sac6 0.39
8 AFUA_2G11010 9 Dihydroorotate reductase PyrE 0.15
10 0.37
9 AFUA_2G11150 12 Secretory pathway gdp dissociation
inhibitor
0.49
10 AFUA_3G00590 41 Asp-hemolysin 0.36
11 AFUA_3G08420 34 Cystathionine beta-synthase
(beta-thionase)
0.45
12 AFUA_3G12300 39 60s ribosomal protein L22 0.37 5.60
13 AFUA_4G03410 13 Flavohemoprotein 0.28 0.05
14 0.32
14 AFUA_4G08240 19 Zinc-containing alcohol
dehydrogenase
0.47 0.05
15 AFUA_4G11080 40 Acetyl-coenzyme A synthetase FacA 2.40 0.29
16 AFUA_5G02370 6 Vacuolar ATP synthase catalytic
subunit A
0.39
17 AFUA_5G06240 18 Alcohol dehydrogenase, putative 0.24 0.15
23 0.35
18 AFUA_5G09910 33 Nitroreductase family protein 0.38 0.12
19 AFUA_5G14680 29 Conserved hypothetical protein 0.20 0.25
30 0.32
31 0.14
20 AFUA_6G02420 43 Ubiquitin conjugating enzyme (UbcM) 2.01 4.77
21 AFUA_6G02750 36 Nascent polypeptide-associated
complex (NAC) subunit
0.42 2.09
22 AFUA_6G05210 27 Malate dehydrogenase,
NAD-dependent
2.12
23 AFUA_6G07430 7 Pyruvate kinase 0.45 0.43
24 AFUA_7G01010 19 Alcohol dehydrogenase 0.47 83.45
25 AFUA_8G03930 3 Hsp70 chaperone (HscA) 0.46 0.46
4 0.49
5 0.45
aSpot number in Figure 4.
bAverage ratios compared under biofilm and planctonic growth conditions were extracted from statistical analysis of DIGE gels by the Delta2D 4.3 (Decodon)
software program. “>2” a consistent increase of greater than twofold. “<2” a consistent decrease of more than twofold.
cThe transcriptional changes determined by RNA-seq are aligned.
information offers an exciting potential to answer many ques-
tions asked by a biological study. However, even if the utilization
of different “omics” methods can be complementary, the com-
bination of the different data obtained remains a challenge.
Among the three “omics” methods used to identify the spe-
cific signature of the A. fumigatus BF, the RNA-sequencing has
exceeded microarrays and is the most powerful analysis giving
precise information on the expression of the entire genes of the
genome in a biological sample with a few degree of variability.
RNA-sequencing has allowed the identification of up regulated
genes involved in transport, secondary metabolism, antigenic
and allergenic molecules during BF growth. Data obtained have
reflected the metabolic reorganization occurring in the BF.
Thus, RNA-sequencing allows the identification of the genes
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differentially expressed between two biological conditions, but it
also provides information concerning sequence variations such
as alternative splicing events, gene fusion detection, and small
RNA characterization at single-nucleotide resolution (Morozova
et al., 2009). In contrast, proteomic analysis allows the identifica-
tion of proteins, the final product of the gene expression, but the
information collected is limited due to the high dynamic range
of protein concentration within a cell and the difficulties in ana-
lyzing membrane proteins. However, the tremendous progress
in LC-MS/MS-based proteomics, which has recently been made,
opens up the possibility to detect and quantify also low abundant,
highly glycosylated, and hydrophobic proteins including mem-
brane proteins (Savas et al., 2011). To date even though these
“omics” technologies are very appealing, the data obtained so
far have not yet been able to solve the identification of virulence
factors in A. fumigatus. Due to the opportunistic pathogenicity
of the species, the identification of the essential metabolic path-
ways under in vivo conditions may be a better option than the
search for specific virulence factors. In this option, “omics” tech-
nologies have a great future in the field of human-pathogenic
fungi.
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